Fundraising FoxTemprian Oncology
1 known investors
Find your way into Temprian Oncology
Sign up to find every way you can get introduced to Temprian Oncology
- Your email: who you already know at Temprian Oncology, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Temprian Oncology team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Temprian Oncology develops nanoparticle-based "Supercarriers" that deliver a prodrug toxic to melanoma cells, releasing the active ingredient inside metastatic melanoma tumor cells in low-pH pigment-making organelles. The therapy targets late-stage, metastasized melanoma and is designed to work alongside or replace existing TKI and immune checkpoint inhibitor treatments.
Investors · 1
Frequently asked questions
- What does Temprian Oncology do?
- Temprian Oncology develops nanoparticle-based "Supercarriers" that deliver a prodrug toxic to melanoma cells, releasing the active ingredient inside metastatic melanoma tumor cells in low-pH pigment-making organelles. The therapy targets late-stage, metastasized melanoma and is designed to work alongside or replace existing TKI and immune checkpoint inhibitor treatments.
- Who are Temprian Oncology's investors?
- Temprian Oncology's investors include 2Flo Ventures.